This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Clinical

Combination therapy with metformin reduces all-cause mortality in type 2 diabetes
Combination therapy with metformin reduces all-cause mortality in type 2 diabetes
New guidelines issued for patients with moderate-to-severe ulcerative colitis
New guidelines issued for patients with moderate-to-severe ulcerative colitis
Gut microbiome and COVID-19: Is there a connection?
Gut microbiome and COVID-19: Is there a connection?
Prednisolone maintenance minimises relapse in quiescent SLE
Prednisolone maintenance minimises relapse in quiescent SLE
Still no effective treatment for patients with CLE
Still no effective treatment for patients with CLE
Hydroxychloroquine not protective in those with SLE
Hydroxychloroquine not protective in those with SLE
Ocular allergic rhinitis symptoms equally improved by intranasal triamcinolone and fluticasone
Ocular allergic rhinitis symptoms equally improved by intranasal triamcinolone and fluticasone
Addition of rituximab improves survival in children with B-cell lymphomas
Addition of rituximab improves survival in children with B-cell lymphomas
Children show increase in mental health difficulties over COVID-19 lockdown
Children show increase in mental health difficulties over COVID-19 lockdown
Parents of children with asthma value written information from their specialist
Parents of children with asthma value written information from their specialist
Health outcomes in cardiovascular disease better for women than men
Health outcomes in cardiovascular disease better for women than men
Increased physical activity equals reduced cancer risk in older adults
Increased physical activity equals reduced cancer risk in older adults


Popular articles

JCVI advises on next round of Covid booster vaccinations
Severe asthma mAb approved in pre-filled single use pen for self-administration
Metomidate scan enables diagnosis of primary aldosteronism
Influenza vaccine approved for treatment and prevention in children aged one year and above
Glyphosate use associated with elevated biomarkers of oxidative DNA damage




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora